TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kindstar Globalgene Technology, Inc. ( (HK:9960) ) has shared an update.
Kindstar Globalgene Technology, Inc. has issued a profit warning, anticipating a net loss of RMB30 million to RMB35 million for the first half of 2025, compared to a net profit of RMB10.5 million in the same period of 2024. The losses are attributed to a decrease in revenue, losses from fair value changes on funds, expected credit losses related to COVID-19, and expenses from recent acquisitions. Despite these challenges, the company’s core business remains stable.
The most recent analyst rating on (HK:9960) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Kindstar Globalgene Technology, Inc. stock, see the HK:9960 Stock Forecast page.
More about Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. operates in the biotechnology industry, focusing on providing specialized diagnostic services and solutions. The company is involved in the acquisition of other biotech firms to expand its market presence.
Average Trading Volume: 965,937
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.77B
See more data about 9960 stock on TipRanks’ Stock Analysis page.